Free Standard AU & NZ Shipping For All Book Orders Over $80!
Register      Login
Healthcare Infection Healthcare Infection Society
Official Journal of the Australasian College for Infection Prevention and Control
RESEARCH ARTICLE (Open Access)

Staphylococcus aureus bloodstream infections: an important indicator for infection control. Chapter 2: Bloodstream infections – an abridged version

Peter Collignon A B E , Marilyn Cruickshank C and Dianne Dreimanis D
+ Author Affiliations
- Author Affiliations

A Infectious Diseases Unit and Microbiology Department, Canberra Hospital, ACT 2606, Australia.

B School of Clinical Medicine, Australian National University, PO Box 11, Woden, ACT 2606, Australia.

C Australian Commission on Safety and Quality in Healthcare, Level 7, 1 Oxford Street, Darlinghurst, NSW 2010, Australia.

D Canberra Hospital, PO Box 11, Woden, ACT 2606, Australia.

E Corresponding author. Email: peter.collignon@act.gov.au

Healthcare Infection 14(4) 165-171 https://doi.org/10.1071/HI09013
Published: 21 December 2009

Abstract

Staphylococcus aureus bloodstream (SAB) infections are common and serious causes of morbidity and mortality. They also cause considerable additional healthcare costs. In Australia, there are ~7000 SAB infection episodes per year and most of these are associated with healthcare procedures. In hospitals, data on all S. aureus bacteraemia episodes are relatively easy to collect. Collecting this data gives an accurate indication of the incidence of SAB infection in individual hospitals and whether they are healthcare-related infections (e.g. arising from intravenous catheter infections or surgical sites). These data also measure the relative proportion of methicillin-resistant S. aureus infections. When hospitals investigate the causes of individual healthcare-associated SAB infections, preventable factors will be identified. This should result in changes in clinical practice and protocols, while ongoing surveillance will allow an assessment of the efficacy of control measures. This will result in a decrease in the number of serious and life-threatening infections. This article is an abridged version of Chapter 2: ‘Bloodstream infections’ from the publication ‘Reducing harm to patients from health care associated infection: the role of surveillance.’ Cruickshank M, Ferguson J, editors. Sydney: Australian Commission on Safety and Quality in Health Care; 2008. The complete publication is available online at: www.safetyandquality.gov.au.


Acknowledgements

We gratefully appreciate the efforts of the original authors of the bloodstream chapter in the Australian Commission on Safety and Quality in Healthcare publication Reducing Harm to Patients from Health Care Associated Infections: The Role of Surveillance, not involved in this article: J Ferguson, H van Gessel, P Taylor, I Wilkinson and L Worth. We also thank Wendy Beckingham of the Canberra Hospital for her contribution to the article.


References


[1] Collignon P,  Nimmo GR,  Gottlieb T,  Gosbell IB. Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis 2005; 11 554–61.
PubMed | [verified October 2009]

[5] Nimmo G,  Pearson J,  Collignon P,  Christiansen K,  Coombs G,  Bell J, et al. Prevalence of MRSA among Staphylococcus aureus isolated from hospital inpatients, 2005: report from the Australian Group for Antimicrobial Resistance. Commun Dis Intell 2007; 31 288–96.
PubMed | [verified October 2009]

[7] Wisplinghoff H,  Bischoff T,  Tallent S,  Seifert H,  Wenzel R,  Edmond M. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39 309–17.
Crossref | GoogleScholarGoogle Scholar | PubMed | [verified October 2009]

[20] Ferguson J,  Gessel H. Methicillin-resistant Staphylococcus aureus in hospitals: time for a culture change Med J Aust 2008; 188 61–4.
[verified October 2009]

[22] Abramson MA,  Sexton DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999; 20 408–11.
Crossref | GoogleScholarGoogle Scholar | CAS | PubMed | [accessed March 2008]